AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Clinical trial NCT00493441 · TERMINATED
Trial details
- NCT number
- NCT00493441
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.